Skip to main content
. 2016 Apr 18;353:i1754. doi: 10.1136/bmj.i1754

Table 2.

Characteristics of included patients

Trial AIMT arm   Medical care (intravenous rt-PA) arm
Intervention No of patients* Mean (SD) age (years) No (%) men Mean (SD) NIHSS Intervention No of patients* Mean (SD) age (years) No (%) men Mean (SD) NIHSS
IMS III28 IV rt-PA with or without IV heparin with or without thrombectomy and/or IA rt-PA 434 63 (SD) 11.07 218 (50.2) 20 (SD) 5.54   IV rt-PA 222 61 (SD) 10.23 122 (55.0) 18 (SD) 3.69
SYNTHESIS29 IV heparin with or without thrombectomy and/or IA rt-PA 181 66 (SD) 11 106 (59) 13 (SD) 5.98   IV rt-PA 181 67 (SD) 11 103 (57) 13 (SD) 6.73
MR RESCUE30 Thrombectomy with or without IA rt-PA with or without IV heparin with or without IV rt-PA 70*/64† 64 (SD) 12.78† 30 (46.9)† 17 (SD) 4.72†   With or without IV rt-PA 57*/54† 67 (SD) 16.48† 27 (50)† 17 (SD) 5.73†
MR CLEAN31 With or without IV rt-PA+thrombectomy with or without IA rt-PA or IA uPA 233 65 (SD) 16.04 135 (57.9) 17 (SD) 5.22   With or without IV rt-PA 267 66 (SD) 15.58 157 (58.8) 18 (SD) 5.96
ESCAPE32 Thrombectomy with or without IV rt-PA 165 71 (SD) 15.71 79 (47.9) 16 (SD) 5.24   With or without IV rt-PA 150 70 (SD) 15.72 71 (47.3) 16 (SD) 5.99
EXTEND-IA33 IV rt-PA with or without thrombectomy 35 69 (SD) 12.3 17 (49) 17 (SD) 5.41   IV rt-PA 35 70 (SD) 11.8 17 (49) 14 (SD) 7.73
SWIFT PRIME34 IV rt-PA with or without thrombectomy 98*/98‡ 65 (SD) 12.5† 54 (55.1)† 17 (SD) 5.27†   IV rt-PA 98*/93‡ 66 (SD) 11.3† 45 (48.4)† 16 (SD) 4.52†
REVASCAT35 Thrombectomy with or without IV rt-PA 103 66 (SD) 11.3 55 (53.4) 17 (SD) 4.51   With or without IV rt-PA 103 67 (SD) 9.5 54 (52.4) 16 (SD) 5.26
THERAPY36 IV rt-PA with or without thrombectomy 55 67 (SD) 11.4 34 (61.8) 17 (SD) 6.05   IV rt-PA 53 70 (SD) 10.3 23 (43.9) 18 (SD) 5.38
THRACE37 IV rt-PA with or without thrombectomy 190 NS NS NS   IV rt-PA 195 NS NS NS

AIMT=adjuvant intra-arterial mechanical thrombolysis; IA=intra-arterial; IV=intravenous; NIHSS=National Institute of Health stroke scale; NS=not specified; rt-PA=recombinant tissue plasminogen activator; uPA=urokinase-type plasminogen activator.

*Intention to treat population.

†Modified intention to treat population.